SGLT2 inhibitor(Topia Life Sciences)

N/A

Report date: 2025/12/31 17:56:57
NME

Base Information

Drug NameSGLT2 inhibitor(Topia Life Sciences)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 2
Therapy Area/IndicationsDiabetes MellitusHypertensionCardio-Renal Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTopia Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesTopia Life Sciences
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusHypertensionCardio-Renal Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A